Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |